The editors gratefully acknowledge all contributors to The ASCO Post and thank the columnists who contributed to Volume 2, January–December 2011:
- Al B. Benson III, MD, FACP
- Richard Boxer, MD, FACS
- Carlton G. Brown, RN, PhD, AOCN
- Barrie R. Cassileth, PhD
- E. David Crawford, MD
- Emil J. Freireich, MD, DSc (Hon)
- John Goodman, PhD
- Jimmie Holland, MD
- Gabriel N. Hortobagyi, MD
- Nora A. Janjan, MD, MPSA, MBA
- Hagop M. Kantarjian, MD
- Theodore S. Lawrence, MD, PhD
- Mary S. McCabe, RN, MA
- Derek Raghavan, MD, PhD
- Elizabeth Reed, MD
- Eliezer Robinson, MD
- George W. Sledge, Jr, MD
- Thomas J. Smith, MD, FACP
- Joshua Spendlove, MD
- Deb Stewart, BSN, RN, CBCN, BPNC-IC
- Marvin J. Stone, MD, MACP
- Daniel A. Vorobiof, MD
- Congresswoman Deborah Wasserman Schultz (D-FL)
- Stanley Winokur, MD
Selected thoughts published over the past year in The ASCO Post appear here. We invite readers to visit the complete archive online at ASCOPost.com.
On ASCO
“The power of ASCO is that its members are usually the best doctors in each country.”
—Eduardo L. Cazap, MD, PhD
Volume 2, Issue 17
“Today, thanks to a vigorous International Affairs Committee, ASCO influences oncology services on all four corners of the world.”
—Gabriel N. Hortobagyi, MD
Volume 2, Issue 8
On Being an Oncologist
“When you combine human kindness with scientific drive, you pave the road for unlimited success.”
—Alexandra Levine, MD, MACP
Volume 2, Issue 17
“American physicians will use their … limitless commitment to excellence to continue to improve health-care quality, service, and patient outcomes.”
—Richard Boxer, MD
Volume 2, Issue 15
“Patients always come first.”
—George W. Sledge, Jr, MD
ASCO President, 2010-2011
Volume 2, Issue 8
“You can learn almost everything you want to know about human behavior by sitting at a patient’s bedside and listening. My life has become bigger and richer by sharing these intimate times with people from all walks of life I otherwise would never have known.”
—Alexandra Levine, MD, MACP
Volume 2, Issue 17
On Cost of Care
“The cuts to oncology being proposed have little effect on the overall budget … but will hamper an already fiscally challenged cancer care delivery system.”
—Shelagh Foster
Director of Government Relations
ASCO, Volume 2, Issue 15
“We need a new payment model that promotes quality of care instead of the current system that promotes quantity of care.”
—Diane Meier, MD, FACP
Volume 2, Issue 14
On the Oncology Drug Shortage
“The greatness of a civilized society is measured by how well it treats its weakest members—the sick and the poor.”
—Hagop M. Kantarjian, MD
Volume 2, Issue 17
“The gains in the curable malignancies have resulted from a hard-fought war, and now it is particularly galling to see the slow, steady, and continued emergence of a national travesty—the shortage of cytotoxic drugs, which will certainly lead to an epidemic of avoidable deaths.”
—Derek Raghavan, MD, PhD
Volume 2, Issue 13
On Disparities
“A cancer diagnosis is no longer the death sentence it used to be, and the statistics are only getting better. But our health-care system is still rife with disparities that prevent these advances from reaching everyone.”
—Congresswoman Debbie
Wasserman Schultz
Volume 2, Issue 15
On Research
“Where is the evidence that protons can be used to safely to deliver a higher dose of radiation than photons to, for example, the prostate?”
—Theodore S. Lawrence, MD, PhD
Volume 2, Issue 14
“Scientists often say that one cannot predict what small finding will lead to major changes, and that is true. But there are limits to the logic, and with limited funds and a crushing debt, one must use common sense.”
—Richard J. Boxer, MD
Volume 2, Issue 7
“Oncologic medicine works best when it is collaborative, and we must understand the view and needs of scientists, physicians, payers, and all the other participants in our complex health-care system.”
—Elizabeth Reed, MD
Volume 2, Issue 2
On Quality of Life
“Patients who enroll in hospice for even 1 day, compared to those who do not, live weeks longer with better quality of life.”
—Thomas J. Smith, MD
Volume 2, Issue 5
On Survivorship
“Making survivorship a formal focus in oncology care will occur incrementally and require attention to evidence, value, quality, professional collaboration, and patient satisfaction.”
—Mary S. McCabe, RN, MA
Volume 2, Issue 3
On Health-care Reform
“Comparative effectiveness assessments that include quality-adjusted life-year calculations will increasingly influence practice guidelines and reimbursement.”
—Nora Janjan, MD, MPSA, MBA
Volume 2, Issue 1
Editor’s note: Readers are encouraged to share their opinions and perspectives on issues of importance to the oncology community. Write to editor@ASCOPost.com. All submissions will be considered for publication.
